中华医学杂志（英文版）2006，Vol.119Issue(1)：63-68,6.
Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
1
作者信息
- 1. Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
- 折叠
摘要
关键词
non-small cell lung cancer/gefitinib/treatmentKey words
non-small cell lung cancer/gefitinib/treatment分类
医药卫生引用本文复制引用
..Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer[J].中华医学杂志（英文版）,2006,119(1):63-68,6.
